Home » Conferences & Events » Health Care » Drug Discovery and Development

Drug Discovery and Development

Podcast Part I: John Sterling, Editor in Chief of Genetic Engineering and Biotechnology News (GEN)
April 26, 2012

John discusses the state of the industry and what he expects will be the top three issues...

NIAMS Scientists: RA Drug Halts Organ Damage in Inflammatory Genetic Disorder
April 1, 2012

A new study shows that Kineret (anakinra), a medication approved for the treatment of...

Take the PKD Foundation Challenge
March 7, 2012

Gary Godsey, President and CEO of the PKD Foundation, explains what resources the Foundation...

Podcast: Dr. Steve Perrin, ALS Therapy Development Institute
January 25, 2012

The ALS Therapy Development Institute will be presenting at the...

More Articles →

Letters, Testimony & Comments

BIO's Testimony to the House Appropriations, Labor HHS Subcommittee on the President's FY 2013 Budget Request for the National Institutes of Health (NIH)
March 20 2012
Good morning Chairman Rehberg, Ranking Member DeLauro, Members of the Committee, ladies, and gentlemen. I am Scott Koenig, President and...
Orphan Drugs: BIO Submits Comments on Orphan Drug Regulations
January 17 2012
  Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the...
Risk-Based Monitoring: BIO Comments on Draft Guidance for Industry on Oversight of Clinical Investigations: A Risk-Based Approach to Monitoring
November 28 2011
  The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit...
BIO Statement for the Presidential Commission for the Presidential Commission for the Study of Bioethical Issues on Principles Regarding Ethical Performance of International Clinical Trials
November 16 2011
Given by Russell M. Medford, MD, PhD President and CEO, Salutria Pharmaceuticals, LLC BIO Board Standing Committee on Bioethics Co-...
BIO Requests for FY 2012 Agriculture, Rural Development, FDA and Related Agencies Appropriations Act
May 12 2011
Dear Chairman Kingston and Ranking Member Farr: On behalf of the Biotechnology Industry Organization (BIO), I am writing to encourage...
More Letters, Testimony & Comments →

Press Releases

BIO Supports Permanent Reauthorization of Programs to Encourage Development of Lifesaving Medications for Children
March 28 2012
Washington, D.C. (March 28, 2012) – BIO President and CEO Jim Greenwood issued the following statement in...
BIO Statement on New Bill to Extend Therapeutic Discovery Project Tax Credit
May 25 2011
WASHINGTON, D.C. (Wednesday, May 25, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim...
Representative Upton Honored as BIO Legislator of the Year
May 4 2011
WASHINGTON, D.C. (Tuesday, May 04, 2011) - The Biotechnology Industry Organization (BIO) announced today its...
Senator Casey Honored as BIO Legislator of the Year
May 4 2011
Pennsylvania Bio President Christopher Molineaux and BIO President and CEO Jim Greenwood present Senator...
Congressman Price Honored as BIO Legislator of the Year
May 4 2011
WASHINGTON, D.C. (Tuesday, May 04, 2011) - The Biotechnology Industry Organization (BIO) announced today its...
More Press Releases →